TickerFacts.

Zeo ScientifiX, Inc. (ZEOX): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2021-10-31, 2023-10-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$23.0K
Year ended 2025-10-31
$824.7K2015-10-31: $1.7K2016-10-31: $26.3K2017-10-31: $45.1K2018-10-31: $4.6K2019-10-31: $32.7K2020-10-31: $138.7K2021-10-31: $424.7K2022-10-31: $824.7K2023-10-31: $26.0K2025-10-31: $23.0K$23.0K
2015-10-31 Capital Expenditures (USD) 2025-10-31
Period endedCapital ExpendituresChange YoYSource filing
2025-10-31$23.0Kn/a2026-01-29, From 2024-11-01
No annual figure between 2023-10-31 and 2025-10-31.
2023-10-31$26.0Kn/c2025-01-29, From 2022-11-01
2022-10-31$824.7K+94.2%2024-01-29, From 2021-11-01
2021-10-31$424.7Kn/c2023-02-14, From 2020-11-01
2020-10-31$138.7K+323.7%2022-02-14, From 2019-11-01
2019-10-31$32.7K+616.5%2021-02-08, From 2018-11-01
2018-10-31$4.6K-89.9%2020-10-16, From 2017-11-01
2017-10-31$45.1K+71.5%2020-03-06, From 2016-11-01
2016-10-31$26.3Kn/m2018-11-01, From 2015-11-01
2015-10-31$1.7Kn/a2017-07-07, From 2014-11-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Zeo ScientifiX, Inc. (ZEOX)2025-10-31$23.0Kn/a
DBV Technologies S.A. (DBVT)2025-12-31$532.0K-77.2%
Prime Medicine, Inc. (PRME)2025-12-31$4.53M-37.9%
Ocugen, Inc. (OCGN)2025-12-31$185.0K-94.5%
Fate Therapeutics Inc (FATE)2025-12-31$5.95M+715.5%
CG Oncology, Inc. (CGON)2025-12-31$134.0K-42.7%
CRISPR Therapeutics AG (CRSP)2025-12-31$914.0K-51.9%
Surrozen, Inc. (SRZN)2025-12-31$128.0K+392.3%
Taysha Gene Therapies, Inc. (TSHA)2025-12-31$738.0K+97.3%

Compare ZEOX, DBVT, PRME, OCGN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗